Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Everly

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Hepatology (Baltimore, Md.)|September 20, 2018
Prevalence and Impact of De Novo Donor-Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant RecipientsVadim Jucaud, Abraham Shaked, Michele DesMarais, et al.
Experimental and Molecular Pathology|December 1, 2015
Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejectionJunchao Cai, Paul I Terasaki, Dong Zhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2017
Nature and Clonality of the Fluoresceinated Secondary Antibody in Luminex Multiplex Bead Assays Are Critical Factors for Reliable Monitoring of Serum HLA Antibody Levels in Patients for Donor Organ Selection, Desensitization Therapy, and Assessment of the Risk for Graft LossMepur H Ravindranath, Vadim Jucaud, Nubia Banuelos, et al.
Pediatric Transplantation|September 19, 2019
Pediatric intestinal transplantation: Analysis of the intestinal transplant registryVikram K Raghu, Jennifer L Beaumont, Matthew J Everly, et al.
Clinical Transplants|June 1, 2013
Changes in IgG subclasses of donor specific anti-HLA antibodies following bortezomib-based therapy for antibody mediated rejectionDinesh Kannabhiran, Matthew J Everly, Jennifer K Walker-McDermott, et al.
Transplantation|January 16, 2010
Beyond histology: lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejectionMatthew J Everly, Lorita M Rebellato, Mikki Ozawa, et al.
Clinical Transplantation|June 22, 2016
Incidence and impact of anti-HLA-DP antibodies in renal transplantationMareike Hörmann, Georg Dieplinger, Lorita M Rebellato, et al.
Transplantation|August 7, 2019
Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated RejectionBong-Ha Shin, Matthew J Everly, Hao Zhang, et al.
Clinical Transplants|May 18, 2017
Risk Stratification of Human Leukocyte Antigen Class II Donor Specific Antibody Positive Patients by Immunoglobulin G SubclassesMichiko Taniguchi, Lorita M Rebellato, Kimberly P Briley, et al.
Clinical Transplants|August 19, 2015
Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid EscalationLorita M Rebellato, Karen Parker, Matthew J Everly, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|September 20, 2018
Prevalence and Impact of De Novo Donor-Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant RecipientsVadim Jucaud, Abraham Shaked, Michele DesMarais, et al.
Experimental and Molecular Pathology|December 1, 2015
Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejectionJunchao Cai, Paul I Terasaki, Dong Zhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2017
Nature and Clonality of the Fluoresceinated Secondary Antibody in Luminex Multiplex Bead Assays Are Critical Factors for Reliable Monitoring of Serum HLA Antibody Levels in Patients for Donor Organ Selection, Desensitization Therapy, and Assessment of the Risk for Graft LossMepur H Ravindranath, Vadim Jucaud, Nubia Banuelos, et al.
Pediatric Transplantation|September 19, 2019
Pediatric intestinal transplantation: Analysis of the intestinal transplant registryVikram K Raghu, Jennifer L Beaumont, Matthew J Everly, et al.
Clinical Transplants|June 1, 2013
Changes in IgG subclasses of donor specific anti-HLA antibodies following bortezomib-based therapy for antibody mediated rejectionDinesh Kannabhiran, Matthew J Everly, Jennifer K Walker-McDermott, et al.
Transplantation|January 16, 2010
Beyond histology: lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejectionMatthew J Everly, Lorita M Rebellato, Mikki Ozawa, et al.
Clinical Transplantation|June 22, 2016
Incidence and impact of anti-HLA-DP antibodies in renal transplantationMareike Hörmann, Georg Dieplinger, Lorita M Rebellato, et al.
Transplantation|August 7, 2019
Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated RejectionBong-Ha Shin, Matthew J Everly, Hao Zhang, et al.
Clinical Transplants|May 18, 2017
Risk Stratification of Human Leukocyte Antigen Class II Donor Specific Antibody Positive Patients by Immunoglobulin G SubclassesMichiko Taniguchi, Lorita M Rebellato, Kimberly P Briley, et al.
Clinical Transplants|August 19, 2015
Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid EscalationLorita M Rebellato, Karen Parker, Matthew J Everly, et al.
Pageof 7